Lena Mallon1, Jan-Erik Broman, Jerker Hetta. 1. Department of Neuroscience, Psychiatry, Uppsala University, University Hospital, SE-75185 Uppsala, Sweden. lena.mallon@ltdalarna.se <lena.mallon@ltdalarna.se>
Abstract
OBJECTIVE: To investigate the influence of hypnotic usage on all-cause and cause-specific mortality in a middle-aged population. METHODS: A cohort of 1750 men and 1773 women aged 30-65 years who responded to a postal questionnaire in 1983. The questionnaire included questions about hypnotic usage, sleep duration, sleep complaints, medical conditions, depression, demographic and life style variables. Mortality data for the period 1983-2003 were collected. RESULTS: Regular hypnotic usage was reported by 1.7% of men and 2.2% of women, and was associated with short sleep, sleeping difficulties, several health problems and depression. During the 20-year follow-up period 379 men (21.5%) and 278 women (15.5%) died. After adjustment for potential risk factors in multivariate analyses regular hypnotic usage was associated with significantly increased risk of all-cause mortality in men (Hazard ratios [HR], 4.54; 95% confidence interval [CI], 2.47-8.37) and in women 2.03 (95% CI, 1.07-3.86). With regard to cause-specific mortality, regular hypnotic usage in men was a risk factor for coronary artery disease death, cancer death, suicide and death from "all remaining causes." In women it was a risk factor for suicide. CONCLUSIONS: Our results show an increased risk of all-cause mortality and cause-specific mortality in regular users of hypnotics.
OBJECTIVE: To investigate the influence of hypnotic usage on all-cause and cause-specific mortality in a middle-aged population. METHODS: A cohort of 1750 men and 1773 women aged 30-65 years who responded to a postal questionnaire in 1983. The questionnaire included questions about hypnotic usage, sleep duration, sleep complaints, medical conditions, depression, demographic and life style variables. Mortality data for the period 1983-2003 were collected. RESULTS: Regular hypnotic usage was reported by 1.7% of men and 2.2% of women, and was associated with short sleep, sleeping difficulties, several health problems and depression. During the 20-year follow-up period 379 men (21.5%) and 278 women (15.5%) died. After adjustment for potential risk factors in multivariate analyses regular hypnotic usage was associated with significantly increased risk of all-cause mortality in men (Hazard ratios [HR], 4.54; 95% confidence interval [CI], 2.47-8.37) and in women 2.03 (95% CI, 1.07-3.86). With regard to cause-specific mortality, regular hypnotic usage in men was a risk factor for coronary artery disease death, cancer death, suicide and death from "all remaining causes." In women it was a risk factor for suicide. CONCLUSIONS: Our results show an increased risk of all-cause mortality and cause-specific mortality in regular users of hypnotics.
Authors: W Vaughn McCall; Jill N Blocker; Ralph D'Agostino; James Kimball; Niki Boggs; Barbara Lasater; Roger Haskett; Andrew Krystal; William M McDonald; Peter B Rosenquist Journal: J Clin Sleep Med Date: 2010-08-15 Impact factor: 4.062
Authors: Matthew P Buman; Christopher E Kline; Shawn D Youngstedt; Barbara Phillips; Marco Tulio de Mello; Max Hirshkowitz Journal: Chest Date: 2015-03 Impact factor: 9.410
Authors: W Vaughn McCall; Ruth M Benca; Peter B Rosenquist; Mary Anne Riley; Laryssa McCloud; Jill C Newman; Doug Case; Meredith Rumble; Andrew D Krystal Journal: Am J Psychiatry Date: 2016-09-09 Impact factor: 18.112
Authors: Megan E Petrov; Virginia J Howard; Dawn Kleindorfer; Michael A Grandner; Jennifer R Molano; George Howard Journal: J Stroke Cerebrovasc Dis Date: 2014-08-10 Impact factor: 2.136
Authors: Jill E Lavigne; Kwan Hur; Cathleen Kane; Anthony Au; Todd M Bishop; Wilfred R Pigeon Journal: J Gen Intern Med Date: 2019-06-03 Impact factor: 5.128